Concepedia

Scott A. Rollins

SA

51

Publications

9.3K

Citations

38

H-Index

1989

Active since

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Alexion Pharma (Switzerland)

Oklahoma Medical Research Foundation

Yale University

Brigham and Women's Hospital

Scott A. Rollins is an author at Alexion Pharmaceuticals (United States) specializing in medicine, immunology, and complement system.

ORCID

Top concepts

Publications per year

1989–2016

51

Publications

51

The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, Neal S. Young, Jörg Schubert et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

Kenneth I. Ataga, Abdullah Kutlar, Julie Kanter et al. · New England Journal of Medicine · 2016 · 837 citations · Full text

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Russell P. Rother, Scott A. Rollins, Christopher F. Mojcik et al. · Nature Biotechnology · 2007 · 752 citations

, , +5

Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, Claire Hall, Judith Marsh et al. · New England Journal of Medicine · 2004 · 631 citations · Full text

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria

Peter Hillmen, Petra Muus, Ulrich Dührsen et al. · Blood · 2007 · 572 citations · Full text

Rows per page

1–5 of 51